SomaLogic Partners With Citogen To Expand Authorized Site Program In Europe
Portfolio Pulse from Benzinga Newsdesk
SomaLogic partners with Citogen, a unit of Longwood Group, to establish its first authorized site in Spain. The collaboration will offer the 7,000-plex SomaScan Assay and provide SomaScan data to customers in Southern Europe for various research disciplines.
June 12, 2023 | 1:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
SomaLogic's partnership with Citogen expands its presence in Europe, potentially increasing demand for its proteomics technology and services.
The partnership with Citogen allows SomaLogic to establish its first authorized site in Spain, expanding its reach in Southern Europe. This collaboration can potentially increase demand for SomaLogic's proteomics technology and services, positively impacting its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100